[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"psychooncology\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:psychooncology":65},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100531992",false,"NCT06207006","E-intervention on Subclinical Fear of Cancer Recurrence","Conquering Fear Online: a Pilot Randomised Controlled Trial Assessing the Efficacy and Feasibility of an Internet-based Self-management Intervention on Subclinical Fear of Cancer Recurrence","Inclusion Criteria:\n\n* Cantonese- or Mandarin-speaking Chinese cancer survivors\n* recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer\n* had recently completed surgery as primary treatment\n* have completed hospital-based adjuvant treatments (including radiotherapy and chemotherapy) within the past six months\n* scored 13 to 21 on the fear of cancer recurrence-short form will be recruited.\n\nExclusion Criteria:\n\n* non-Chinese ethnicity\n* metastatic cancer\n* with current diagnosis of depression or psychosis or are currently receiving psychological treatments\n* language or intellectual difficulties that prevent them from understanding the intervention content\n* having limited or no Internet access.","ALL","18 Years",{"count":18,"type":19},48,"ESTIMATED","INTERVENTIONAL",[22],"NA","The present study aims to adapt a metacognition-based ConquerFear-HK to an internet-based self-management intervention, namely eConquerFear-HK and evaluate in a randomised controlled trial, its feasibility, utility, and potential effectiveness on fear of cancer recurrence reduction among local Chinese cancer survivors with subclinical fear of cancer recurrence.",[25,26,27],"Cancer","Psychooncology","Fear of Cancer Recurrence","RECRUITING","2025-10-01",{"date":31,"type":32},"2025-10-03","ACTUAL",{"date":34,"type":32},"2024-05-02",{"date":36,"type":19},"2025-12-30",{"name":38,"class":39},"The University of Hong Kong","OTHER",1,{"id":42,"slug":4,"hasResults":10,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":47,"targetDuration":4,"studyType":20,"phases":49,"briefSummary":50,"conditions":51,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100491468","NCT05679518","Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches","Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with advanced or metastatic (i.e. stage III or IV) cancer\n* are the age of 18 years or above\n\nExclusion Criteria:\n\n* Patients with major communication difficulties\n* are being unwilling or unable to commit 6 psychotherapy sessions",{"count":48,"type":19},261,[22],"The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progression among Chinese patients diagnosed with advanced cancer.",[52,53,54,55,26],"Advanced or Metastatic Cancer","Fear of Cancer Progression","Metacognition-based Intervention","Supportive-expressive Based Intervention","2025-03-31",{"date":58,"type":32},"2025-04-03",{"date":60,"type":32},"2023-12-20",{"date":62,"type":19},"2026-06-30",{"name":38,"class":39},4,""]